AYTU BIOPHARMA, INC Entity Listing, Par Value Per Share
AYTU BIOPHARMA, INC (AYTU) reported Entity Listing, Par Value Per Share of $0.00 per share for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Notes
dei:EntityListingParValuePerShare · last filed 2023-11-14
- AYTU BIOPHARMA, INC entity listing, par value per share for the quarter ending 2023-09-30 was $0.00, a 0.00% change year-over-year.
- AYTU BIOPHARMA, INC entity listing, par value per share for the quarter ending 2022-09-30 was $0.00, a 0.00% change year-over-year.
- AYTU BIOPHARMA, INC entity listing, par value per share for the quarter ending 2021-09-30 was $0.00.
- AYTU BIOPHARMA, INC entity listing, par value per share for fiscal 2023 was $0.00, a 0.00% change from fiscal 2022.
- AYTU BIOPHARMA, INC entity listing, par value per share for fiscal 2022 was $0.00.
- AYTU BIOPHARMA, INC entity listing, par value per share for fiscal 2011 was $0.15.
| Period end | Entity Listing, Par Value Per Share 3 month | Entity Listing, Par Value Per Share 6 month | Entity Listing, Par Value Per Share 9 month | Entity Listing, Par Value Per Share 12 month |
|---|---|---|---|---|
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 | |||
| 2023-06-30 | $0.00 10-K · filed 2023-10-12 | |||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-11 | |||
| 2022-12-31 | $0.00 10-Q · filed 2023-02-21 | |||
| 2022-09-30 | $0.00 10-Q/A · filed 2023-02-21 | |||
| 2022-06-30 | $0.00 10-K · filed 2022-09-27 | |||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-16 | |||
| 2021-12-31 | $0.00 10-Q · filed 2022-02-14 | |||
| 2021-09-30 | $0.00 10-Q · filed 2021-11-15 | |||
| 2011-08-31 | $0.15 10-K · filed 2012-11-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |